890435-03-7

Upstream product

• 69922-27-6 1-fluoro-2-isocyanato-4-(trifluoromethyl)benzene 
• 18542-98-8 4-fluoro-N,N-dimethyl-3-nitroaniline 
• 890435-04-8 1-(5-bromopyridin-2-yl)-3-(2-fluoro-5-trifluoromethylphenyl)urea 
• 73183-34-3 bis(pinacol)diborane 
• 192819-46-8 4-fluoro-N₁,N₁-dimethylbenzene-1,3-diamine 

Downstream Products

• 898855-08-8 di-tert-butyl {3'-cyano-6-[3-(2-fluoro-5-trifluoromethylphenyl)ureido][3,4']bipyridyl-2'-yl}hydrazinedicarboxylate 
• 898855-03-3 tri-tert-butyl N,N',N'-{3'-cyano-6-[3-(2-fluoro-5-trifluoromethyl phenyl)ureido][3,4']bipyridyl-2'-yl}-hydrazinetricarboxylate 

Relevant academic research and scientific papers

INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME

The present invention relates to compounds of formula (I): wherein Q, G1, G2, and G3, are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.

Substituted Indoles, Compositions Containing Them, Method for the Production Thereof and Their Use

Compounds of formula (I): wherein R1, R5, R6, R7, Ar, L, A, and Q are as defined in the description, and to salts thereof, to compositions containing them, to the process for preparing them, and to their use as medicinal products, in particular as antican

SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS

This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.